These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26296489)

  • 1. mTORC1 and mTORC2 have largely distinct functions in Purkinje cells.
    Angliker N; Burri M; Zaichuk M; Fritschy JM; Rüegg MA
    Eur J Neurosci; 2015 Oct; 42(8):2595-612. PubMed ID: 26296489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.
    Sun J; Liu Y; Moreno S; Baudry M; Bi X
    J Neurosci; 2015 Mar; 35(11):4706-18. PubMed ID: 25788687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology.
    Thomanetz V; Angliker N; Cloëtta D; Lustenberger RM; Schweighauser M; Oliveri F; Suzuki N; Rüegg MA
    J Cell Biol; 2013 Apr; 201(2):293-308. PubMed ID: 23569215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
    Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
    PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation.
    Martin SK; Fitter S; Dutta AK; Matthews MP; Walkley CR; Hall MN; Ruegg MA; Gronthos S; Zannettino AC
    Stem Cells; 2015 Apr; 33(4):1359-65. PubMed ID: 25537496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
    Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
    Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence for mTORC2-mediated actin cytoskeleton rearrangement in neurons.
    Angliker N; Rüegg MA
    Bioarchitecture; 2013; 3(4):113-8. PubMed ID: 24721730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
    Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
    Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival.
    Ma S; Venkatesh A; Langellotto F; Le YZ; Hall MN; Rüegg MA; Punzo C
    Exp Eye Res; 2015 Jun; 135():1-13. PubMed ID: 25887293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury.
    Li J; Xu Z; Jiang L; Mao J; Zeng Z; Fang L; He W; Yuan W; Yang J; Dai C
    Kidney Int; 2014 Jul; 86(1):86-102. PubMed ID: 24451322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.
    Wazir U; Newbold RF; Jiang WG; Sharma AK; Mokbel K
    Oncol Rep; 2013 May; 29(5):1969-74. PubMed ID: 23503572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription.
    Kamano Y; Saeki M; Egusa H; Kakihara Y; Houry WA; Yatani H; Kamisaki Y
    FEBS Lett; 2013 Oct; 587(20):3303-8. PubMed ID: 24036451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression.
    Sticz T; Molnár A; Márk Á; Hajdu M; Nagy N; Végső G; Micsik T; Kopper L; Sebestyén A
    J Clin Pathol; 2017 May; 70(5):410-416. PubMed ID: 27729429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function.
    Kellersch B; Brocker T
    Blood; 2013 Jan; 121(2):298-307. PubMed ID: 23212520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells.
    Sakai Y; Kassai H; Nakayama H; Fukaya M; Maeda T; Nakao K; Hashimoto K; Sakagami H; Kano M; Aiba A
    Sci Rep; 2019 Feb; 9(1):2799. PubMed ID: 30808980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and association of mTOR with its cofactors, raptor and rictor, in cumulus cells and oocytes during meiotic maturation in mice.
    Kogasaka Y; Hoshino Y; Hiradate Y; Tanemura K; Sato E
    Mol Reprod Dev; 2013 Apr; 80(4):334-48. PubMed ID: 23440873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
    Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
    Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K-p110-alpha-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2.
    Wahane SD; Hellbach N; Prentzell MT; Weise SC; Vezzali R; Kreutz C; Timmer J; Krieglstein K; Thedieck K; Vogel T
    J Neurochem; 2014 Jul; 130(2):255-67. PubMed ID: 24645666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.